BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5474113)

  • 1. Responses of mycosis fungoides to intensive external treatment with nitrogen mustard.
    Van Scott EJ; Winters PL
    Arch Dermatol; 1970 Nov; 102(5):507-14. PubMed ID: 5474113
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.
    Waldorf DS; Haynes HA; Van Scott EJ
    Ann Intern Med; 1967 Aug; 67(2):282-90. PubMed ID: 6036390
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
    Liner K; Brown C; McGirt LY
    Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides, nitrogen mustard and skin cancer.
    Du Vivier A; Vonderheid EC; Van Scott EJ; Urbach F
    Br J Dermatol; 1978 Jul; 99(1):61-3. PubMed ID: 678466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
    Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
    J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
    Price NM
    Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical chemotherapy of mycosis fungoides.
    Grekin DA; Zackheim HS; Epstein EH
    Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
    Thestrup-Pedersen K; Christiansen JV; Zachariae H
    Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
    Monk BE; Vollum DI; du Vivier AW
    Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
    [No Abstract]   [Full Text] [Related]  

  • 14. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
    du Vivier A; Vollum DI
    Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical mechlorethamine therapy for early stage mycosis fungoides.
    Ramsay DL; Halperin PS; Zeleniuch-Jacquotte A
    J Am Acad Dermatol; 1988 Oct; 19(4):684-91. PubMed ID: 3183094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
    Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE
    Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
    Kim YH; Martinez G; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urticaria and anaphylactoid reactions after topical application of mechlorethamine.
    Daughters D; Zackheim H; Maibach H
    Arch Dermatol; 1973 Mar; 107(3):429-30. PubMed ID: 4692132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.